Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
Clinical trial NCT04594850 · COMPLETED
Trial details
- NCT number
- NCT04594850
- Sponsor
- Pharmicell Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2026-01-07
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.